Banking Khabar / The IPO (Initial Public Offering) of Sopan Pharmaceuticals Limited has been rescheduled.
Earlier, the company planned to open its IPO for the general public from Baisakh 2. However, the date was changed after the Government of Nepal decided to introduce two weekly public holidays on Saturdays and Sundays. According to NMB Capital Limited, the issue and sales manager, the schedule had to be revised due to this change.
Now, investors can apply for the IPO starting from Baisakh 3, and the application period will close on Baisakh 8.
The company had received approval from the Securities Board of Nepal on Falgun 17 to issue a total of 4.29 million shares at a face value of NPR 100 per share.
Out of the total shares:
- 214,500 shares have been reserved for mutual funds.
- 171,600 shares are set aside for company employees.
- The remaining 3,474,900 shares will be available to the general public.
General investors can apply for a minimum of 10 shares and a maximum of 11,000 shares.
NMB Capital Limited has been appointed as the issue and sales manager for the IPO.
